Eligibility for Cardiovascular Risk Reduction Therapy in the United States Based on SELECT Trial Criteria: Insights From the National Health and Nutrition Examination Survey

By sjmartinez • January 17, 2024

Lu Y, Liu Y, Jastreboff AM, Khera R, Ndumele CD, Rodriguez F, Watson KE, Krumholz HM. Eligibility for Cardiovascular Risk Reduction Therapy in the United States Based on SELECT Trial Criteria: Insights From the National Health and Nutrition Examination Survey. Circ Cardiovasc Qual Outcomes. 2024 Jan;17(1):e010640. doi: 10.1161/CIRCOUTCOMES.123.010640. Epub 2023 Nov 11. Erratum in: Circ Cardiovasc Qual Outcomes. 2024 Jan;17(1):e000126. PMID: 37950677; PMCID: PMC10782930.

Tags: adult, Cardiology/Epi, cardiovascular diseases, Ethnicity, Obesity, overweight, Publications

Mutual Regulation of Cardiovascular and Hematopoietic Development

Liu N, Nakano H, Nakano A. Mutual Regulation of Cardiovascular and Hematopoietic Development. Curr Cardiol Rep. 2025 Apr 22;27(1):86. doi: 10.1007/s11886-025-02236-5. PMID: 40261519.

Systems genetics uncovers associations among host amylase locus, gut microbiome, and metabolic traits in mice

Zhang Q, Hutchison ER, Pan C, Warren MF, Keller MP, Attie AD, Lusis AJ, Rey FE. Systems genetics uncovers associations among host amylase locus, gut[...]

Do Pulmonary Embolism Response Teams in Acute Pulmonary Embolism Improve Outcomes? Insights from a Meta-analysis

Maqsood MH, Zhang RS, Rosenfeld K, Moriarty JM, Rosovsky RP, Horowitz JM, Alviar CL, Bangalore S. Do Pulmonary Embolism Response Teams in Acute Pulmonary Embolism[...]